title: A case of vasculitis in a breast cancer patient treated with T-DM1.
authors.forename: Aarti S
authors.initials: AS
authors.lastname: Bhardwaj
authors.forename: Beth
authors.initials: B
authors.lastname: McLellan
authors.forename: Maria R
authors.initials: MR
authors.lastname: Robinson
authors.forename: Olivia
authors.initials: O
authors.lastname: Ghaw
authors.forename: Lewis R
authors.initials: LR
authors.lastname: Lipsey
authors.forename: Amy D
authors.initials: AD
authors.lastname: Tiersten
authors.forename: Gloria J
authors.initials: GJ
authors.lastname: Morris
mesh_terms: D000080044:Ado-Trastuzumab Emtansine; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001791:Blood Platelet Disorders / Q000139:chemically induced* / Q000473:pathology; D001943:Breast Neoplasms / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D008453:Maytansine / Q000009:adverse effects / Q000031:analogs & derivatives*; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000473:pathology; D000068878:Trastuzumab; D014657:Vasculitis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D008453:Maytansine; D000068878:Trastuzumab; D000080044:Ado-Trastuzumab Emtansine